An anti-HIV peptide, T22, forms a highly active complex with Zn(II).

Biochem Biophys Res Commun

Faculty of Pharmaceutical Sciences, Kyoto University, Japan.

Published: December 1996

T22 ([Tyr5,12, Lys7]-polyphemusin II) has been shown to have strong anti-human immunodeficiency virus (HIV) activity, comparable to that of 3'-azide-2', 3'-dideoxythymidine (AZT). T22 takes an antiparallel beta-sheet structure maintained by two disulfide bridges and contains two antiparallel repeats of Cys-Tyr-Arg-Lys-Cys. As reported herein, fully reduced T22 was found by HPLC and ion spray mass spectrometric analyses to form a complex in a molar ratio of 1:1 with Zn(II) ion at neutral pH in aqueous solution. Complexation of Zn(II) ion to this peptide appears to result in tetracoordinate bonding to sulfur atoms of four Cys residues. We also found that the anti-HIV activity of the T22-Zn(II) complex was fourfold stronger than that of T22.

Download full-text PDF

Source
http://dx.doi.org/10.1006/bbrc.1996.1858DOI Listing

Publication Analysis

Top Keywords

znii ion
8
t22
5
anti-hiv peptide
4
peptide t22
4
t22 forms
4
forms highly
4
highly active
4
active complex
4
complex znii
4
znii t22
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!